iMediSync will showcase a series of EEG analysis solutions for brain mapping at CES 2021. The company is launching its first brain mapping and therapeutic device: combining both EEG brain mapping and LED therapy.
iMediSync has developed a dry sensing EEG brain mapping system with LED photo-biomodulators, iSyncWave. It will work together with iSyncMe – mobile application. Through the app, users will be able to access its cloud-based EEG analysis platform(iSyncBrain), where the AI analyzes for any abnormalities in the brain function. 19 LEDs built-in iSyncWave provide photobiomodulation(PBM) as a non-pharmacological option. The dry sensors make the EEG brain mapping easier and PBM enables a comprehensive therapy at the time of measuring.
At coming CES 2021, iMedisync will build global partnerships with medical device distribution companies, and pharmaceutical or digital therapeutics companies for verification of treatment effect.